SG152267A1 - Polyvalent viral vectors and a system for production thereof - Google Patents

Polyvalent viral vectors and a system for production thereof

Info

Publication number
SG152267A1
SG152267A1 SG200902806-9A SG2009028069A SG152267A1 SG 152267 A1 SG152267 A1 SG 152267A1 SG 2009028069 A SG2009028069 A SG 2009028069A SG 152267 A1 SG152267 A1 SG 152267A1
Authority
SG
Singapore
Prior art keywords
viral vectors
production
polyvalent viral
expression cassettes
polyvalent
Prior art date
Application number
SG200902806-9A
Other languages
English (en)
Inventor
Gao Guangping
James M Wilson
Zhou Xiangyang
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of SG152267A1 publication Critical patent/SG152267A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200902806-9A 2004-04-28 2005-04-27 Polyvalent viral vectors and a system for production thereof SG152267A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56594104P 2004-04-28 2004-04-28

Publications (1)

Publication Number Publication Date
SG152267A1 true SG152267A1 (en) 2009-05-29

Family

ID=34978744

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200902806-9A SG152267A1 (en) 2004-04-28 2005-04-27 Polyvalent viral vectors and a system for production thereof

Country Status (16)

Country Link
US (1) US20070218536A1 (fr)
EP (1) EP1743028A2 (fr)
JP (1) JP5690038B2 (fr)
KR (1) KR20070004877A (fr)
CN (1) CN1965086B (fr)
AU (1) AU2005238527B2 (fr)
BR (1) BRPI0510385A (fr)
CA (1) CA2562893A1 (fr)
IL (1) IL178773A0 (fr)
MA (1) MA28637B1 (fr)
MX (1) MXPA06012511A (fr)
NO (1) NO20065404L (fr)
NZ (1) NZ550411A (fr)
RU (1) RU2416646C2 (fr)
SG (1) SG152267A1 (fr)
WO (1) WO2005106002A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136963A1 (en) * 2001-06-22 2004-07-15 The Trustees Of The University Of Pennsylvania Simian adenovirus vectors and methods of use
NZ550416A (en) 2001-11-21 2008-06-30 Univ Pennsylvania Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
GB2544892B (en) * 2015-11-24 2017-11-15 Glaxosmithkline Ip Dev Ltd Stable cell lines for retroviral production
DE102016122317A1 (de) * 2015-11-24 2017-05-24 Glaxosmithkline Intellectual Property Development Limited Transientes transfektionsverfahren für retrovirale produktion
US20200299651A1 (en) * 2017-10-16 2020-09-24 Glaxosmithkline Biologicals Sa Simian adenoviral vectors with two expression cassettes
CN112206317B (zh) * 2020-10-12 2023-09-22 浙江省淡水水产研究所 一种草鱼出血病二价核酸菌蜕疫苗的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880102A (en) * 1995-01-17 1999-03-09 Duke University Adenoviral vector system
US6096523A (en) * 1998-11-04 2000-08-01 University Of Georgia Research Foundation Transformation vector system
AU3120601A (en) * 2000-01-28 2001-08-07 Scripps Research Inst Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
US20030108524A1 (en) * 2001-10-18 2003-06-12 Melissa Diagana Vectors for expressing multiple transgenes

Also Published As

Publication number Publication date
CN1965086A (zh) 2007-05-16
RU2006141839A (ru) 2008-06-10
US20070218536A1 (en) 2007-09-20
NO20065404L (no) 2007-01-17
CN1965086B (zh) 2012-12-26
NZ550411A (en) 2009-08-28
AU2005238527A1 (en) 2005-11-10
JP2007535326A (ja) 2007-12-06
RU2416646C2 (ru) 2011-04-20
AU2005238527B2 (en) 2011-01-20
WO2005106002A2 (fr) 2005-11-10
WO2005106002A3 (fr) 2006-06-22
MA28637B1 (fr) 2007-06-01
JP5690038B2 (ja) 2015-03-25
IL178773A0 (en) 2007-02-11
EP1743028A2 (fr) 2007-01-17
MXPA06012511A (es) 2006-12-15
CA2562893A1 (fr) 2005-11-10
BRPI0510385A (pt) 2007-11-13
KR20070004877A (ko) 2007-01-09

Similar Documents

Publication Publication Date Title
SG152267A1 (en) Polyvalent viral vectors and a system for production thereof
TW200745585A (en) System, method, and article of manufacture for determining an estimated combined battery state-parameter vector
IL163546A0 (en) An influenza viral vector containing incorporationsequences
IL195338A0 (en) Optimized fc variants and methods for their generation
TW200644472A (en) Codebook generation system and associated methods
GB2437452A (en) Sensing input actions
AU2003238456A1 (en) Viral vector
ATE383804T1 (de) Kindgerechter einwegartikel
PL1668564T3 (pl) Urządzenie do ustawiania użytkownika przez ustalanie położenia obu oczu
NO20063037L (no) Fremgangsmater og midler for immunmodulering og fremgangsmate for a identifisere immunmodulatorer
HK1091617A1 (en) A system and associated method to determine authentication priority between devices
NO20044898L (no) Nye etonogestrel estere
NO20053205L (no) Forbedret fremgangsmate for produksjon av vitamin B12.
AU148078S (en) Bottle
GB0507580D0 (en) Gas generator
TW200626914A (en) Apparatus for fixing a workpiece by magnetic force and fixing unit thereof
CR6912S (es) Envase
DE502005006508D1 (de) Gipskartonständerwand
WO2007074407A3 (fr) Dispositif de levitation
AU2002240847A1 (en) Adhesive label with fluidifying agents for natural airway secretions
EP1536002A4 (fr) Promoteur et vecteur provenant de levure et systeme d'expression faisant intervenir ceux-ci
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
WO2003059264A3 (fr) Procedes d'induction de lymphocytes t regulateurs professionnels et des lymphocytes t produisant des cytokines
IL162493A0 (en) Assay for the detection of factors that modulate the expression of ingap
AU2003267971A8 (en) Improved alphavirus vectors having attenuated virion structural proteins